Rare diseases
Investigational molecules
Locations
Back to Italy2 684 clinical trials in Novara, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
ItalyStudy on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes
ItalyStudy of Pembrolizumab and Drug Combination for Patients with Advanced Esophageal Cancer
ItalyEfficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ItalyStudy on the Effectiveness of Human Normal Immunoglobulin for Adults with Post-COVID-19 Postural Orthostatic Tachycardia Syndrome (POTS)
ItalyStudy on Symptom Changes in Adults with Chronic Rhinosinusitis with Nasal Polyps Using Tezepelumab
ItalyStudy Comparing Zimberelimab and Domvanalimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Untreated Metastatic Non-Small Cell Lung Cancer
ItalyStudy on Guselkumab for Patients with Moderate to Severe Crohn's Disease
ItalyStudy of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease
ItalyItalyStudy of Sotatercept for Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension Patients
ItalyLong-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on hematologic malignancies and solid tumors, investigating innovative treatments for various cancer types including leukemia, breast cancer, and lung cancer.
Studies evaluating combination therapies and targeted treatments to improve patient outcomes.
Research focusing on heart failure prevention and treatment strategies, particularly exploring new drug combinations and their impact on cardiovascular outcomes.
Innovative approaches combining multiple therapeutic agents to address cardiovascular risks.
Investigations into treatments for various autoimmune disorders, including Sjögren's Syndrome and rheumatoid arthritis, with emphasis on novel therapeutic approaches.
Focus on developing targeted therapies for better disease management and patient care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
